HOLUBIAK MYRON Z 13D and 13G filings for Citius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-18 4:30 pm Purchase |
2019-04-03 | 13D | Citius Pharmaceuticals, Inc. CTXR |
HOLUBIAK MYRON Z | 154,584 2.610% |
68,615 (+79.81%) |
Filing |